UK Markets open in 4 hrs 55 mins
NIKKEI 225
27,381.18 +18.43 (+0.07%) HANG SENG
22,583.45 +16.67 (+0.07%) CRUDE OIL
81.29 +0.28 (+0.35%) GOLD FUTURES
1,926.20 -3.80 (-0.20%) DOW
33,949.41 +205.57 (+0.61%) BTC-GBP
18,396.58 -405.63 (-2.16%)
Innate Pharma S.A. (IPHA)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EST
After hours:
Loading interactive chart…
- Business Wire
Innate Pharma Announces HSR Clearance Regarding Expansion of Its Collaboration With Sanofi on NK Cell Engagers
MARSEILLE, France, January 25, 2023--Innate Pharma announces HSR clearance regarding expansion of its collaboration with Sanofi on NK cell engagers
- Business Wire
Innate Pharma Announces Publication of Preclinical Data with a Trifunctional NK Cell Engager in Acute Myeloid Leukemia in Nature Biotechnology
MARSEILLE, France, January 16, 2023--Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") announced today the publication in Nature Biotechnology of preclinical data showing the control of acute myeloid leukemia (AML) cells by a trifunctional NKp46-CD16a-NK cell engager (NKCE) targeting CD123. The studies were conducted by Innate and Sanofi and published in Nature Biotechnology on January 12, 2023.
- Business Wire
Sanofi and Innate Pharma Expand Collaboration for Natural Killer Cell Therapeutics in Oncology
MARSEILLE, France, December 19, 2022--Sanofi and Innate Pharma expand collaboration for Natural Killer cell therapeutics in oncology
© 2023 Yahoo. All rights reserved.
